Search - tctmd.com

Displaying 361 - 380 of 388

Sort: Relevancy | Date

News Daily News

ESSENCE-DIABETES Published: Xience, Cypher Equally Equipped to Treat Diabetics

Caitlin E. Cox

August 03, 2011

News Daily News

Meta-analysis Finds Equivalence Between First-, Second-Generation DES

L.A. McKeown

August 02, 2011

News Daily News

ISAR-TEST 5 Published: Polymer-Free Dual DES Noninferior to Resolute

Jason Kahn

July 21, 2011

News Daily News

DES Show Advantage over BMS for Heart Transplant Complication

L.A. McKeown

July 01, 2011

News Daily News

Study Takes Clopidogrel into Account in Assessing DES Cost-Effectiveness

Caitlin E. Cox

June 24, 2011

News Daily News

Cordis Announces Plans to Discontinue Cypher Stents, Drop Nevo Development

L.A. McKeown

June 15, 2011

News Industry News

Cordis Announces Discontinuation of NEVO Sirolimus-Eluting Coronary Stent

June 15, 2011

News Daily News

EES Show Long-term Safety Advantage over SES

L.A. McKeown

May 24, 2011

News Conference News

Meta-analysis: Biodegradable Polymer DES Reduce Stent Thrombosis, TLR at 3 Years

Caitlin E. Cox

May 20, 2011

News Conference News

Long-Term Imaging Study Evaluates Vascular Healing in First-Gen DES

Jason Kahn

May 19, 2011

News Daily News

Everolimus-Eluting Stents Found Equivalent to First-Generation Stents in Most Patients at 1 Year

Leah Lawrence

April 26, 2011

News Conference News

Therapies Take on In-Stent Restenosis with Mixed Results

Caitlin E. Cox

April 15, 2011

News Conference News

ACC Scientific Session-i2 Summit 2011: The Devil Is in the Details

Caitlin E. Cox

April 08, 2011

News Conference News

PRECOMBAT: PCI with Sirolimus Stent Equivalent to CABG in Left Main Disease

April 05, 2011

News Conference News

ISAR-CABG: DES Superior to BMS in Saphenous Vein Graft Lesions

Jason Kahn

April 04, 2011

News Daily News

Stent Thrombosis, Major Bleeding Rare with Sirolimus-Eluting Stents

March 21, 2011

News Daily News

Restenosis After Left Main Stenting Does Not Affect Long-term Prognosis

March 14, 2011

News Daily News

IVUS Supports Effectiveness of Novel Stent with Bioabsorbable Polymer

L.A. McKeown

March 10, 2011

News Daily News

Studies Support DES Use in Diabetics, But Results Vary by Device

Caitlin E. Cox

March 08, 2011

News Daily News

Autopsy Study: About One-Third of DES Contain New Atherosclerosis

March 01, 2011

Advertisement

ESSENCE-DIABETES Published: Xience, Cypher Equally Equipped to Treat Diabetics

Meta-analysis Finds Equivalence Between First-, Second-Generation DES

ISAR-TEST 5 Published: Polymer-Free Dual DES Noninferior to Resolute

DES Show Advantage over BMS for Heart Transplant Complication

Study Takes Clopidogrel into Account in Assessing DES Cost-Effectiveness

Cordis Announces Plans to Discontinue Cypher Stents, Drop Nevo Development

Cordis Announces Discontinuation of NEVO Sirolimus-Eluting Coronary Stent

EES Show Long-term Safety Advantage over SES

Meta-analysis: Biodegradable Polymer DES Reduce Stent Thrombosis, TLR at 3 Years

Long-Term Imaging Study Evaluates Vascular Healing in First-Gen DES

Everolimus-Eluting Stents Found Equivalent to First-Generation Stents in Most Patients at 1 Year

Therapies Take on In-Stent Restenosis with Mixed Results

ACC Scientific Session-i2 Summit 2011: The Devil Is in the Details

PRECOMBAT: PCI with Sirolimus Stent Equivalent to CABG in Left Main Disease

ISAR-CABG: DES Superior to BMS in Saphenous Vein Graft Lesions

Stent Thrombosis, Major Bleeding Rare with Sirolimus-Eluting Stents

Restenosis After Left Main Stenting Does Not Affect Long-term Prognosis

IVUS Supports Effectiveness of Novel Stent with Bioabsorbable Polymer

Studies Support DES Use in Diabetics, But Results Vary by Device

Autopsy Study: About One-Third of DES Contain New Atherosclerosis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content